
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
GAS41 CRISPR/Cas9 KO Plasmid (m) | sc-425664 | 20 µg | $397.00 |
Mouse Yeats4 encodes GAS41, a YEATS domain–containing chromatin-associated factor that participates in transcriptional regulation by linking histone acetylation signals to chromatin remodeling. GAS41 is reported to associate with epigenetic regulatory complexes, supporting RNA polymerase II–dependent gene expression programs that influence cell-cycle progression, DNA replication, and genome stability. Through its roles in chromatin organization and transcriptional control, Yeats4/GAS41 is relevant to studies of oncogenic transcriptional states, aneuploidy, and stress-response pathways in proliferative tissues. Dysregulation of YEATS family chromatin readers has been connected to altered enhancer activity and transformation-associated gene expression, making Yeats4 a useful node for mechanistic cancer and developmental biology research.
GAS41 CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Yeats4 gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Yeats4 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Yeats4 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish GAS41 protein expression.
This CRISPR knockout system enables efficient generation of Yeats4-deficient cell models for investigation of GAS41 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.